Pharmacogenomics: Bench to bedside

被引:181
作者
Weinshilboum, R [1 ]
Wang, LW [1 ]
机构
[1] Mayo Med Sch Mayo Grad Sch, Mayo Clin Coll Med, Dept Mol Pharmacol & Exp Therapeut, Rochester, MN 55905 USA
关键词
D O I
10.1038/nrd1497
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Pharmacogenetics is the study of the role of inheritance in inter-individual variation in drug response. Since its origins in the mid-twentieth century, a major driving force in pharmacogenetics research has been the promise of individualized drug therapy to maximize drug efficacy and minimize drug toxicity. In recent years, the convergence of advances in pharmacogenetics with rapid developments in human genomics has resulted in the evolution of pharmacogenetics into pharmacogenomics, and led to increasing enthusiasm for the 'translation' of this evolving discipline into clinical practice. Here, we briefly summarize the development of pharmacogenetics and pharmacogenomics, and then discuss the key factors that have had an influence on - and will continue to affect - the translation of pharmacogenomics from the research bench to the bedside, highlighting the challenges that need to be addressed to achieve this goal.
引用
收藏
页码:739 / 748
页数:10
相关论文
共 71 条
[1]  
Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441
[2]   The relative power of SNPs and haplotype as genetic markers for association tests [J].
Bader, JS .
PHARMACOGENOMICS, 2001, 2 (01) :11-24
[3]   PRONOUNCED DIFFERENCES BETWEEN NATIVE CHINESE AND SWEDISH POPULATIONS IN THE POLYMORPHIC HYDROXYLATIONS OF DEBRISOQUIN AND S-MEPHENYTOIN [J].
BERTILSSON, L ;
LOU, YQ ;
DU, YL ;
LIU, Y ;
KUANG, TY ;
LIAO, XM ;
WANG, KY ;
REVIRIEGO, J ;
ISELIUS, L ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (04) :388-397
[4]   Inherited disorders of bilirubin metabolism [J].
Bosma, PJ .
JOURNAL OF HEPATOLOGY, 2003, 38 (01) :107-117
[5]   THE GENETIC-BASIS OF THE REDUCED EXPRESSION OF BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1 IN GILBERTS-SYNDROME [J].
BOSMA, PJ ;
CHOWDHURY, JR ;
BAKKER, C ;
GANTLA, S ;
DEBOER, A ;
OOSTRA, BA ;
LINDHOUT, D ;
TYTGAT, GNJ ;
JANSEN, PLM ;
ELFERINK, RPJO ;
CHOWDHURY, NR .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (18) :1171-1175
[6]   Arylamine N-acetyltransferase activity in man [J].
Cascorbi, I ;
Brockmöller, J ;
Mrozikiewicz, PM ;
Müller, A ;
Roots, I .
DRUG METABOLISM REVIEWS, 1999, 31 (02) :489-502
[7]   Ethical, legal, and social implications of genomic medicine [J].
Clayton, EW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :562-569
[8]   The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations [J].
Collie-Duguid, ESR ;
Pritchard, SC ;
Powrie, RH ;
Sludden, J ;
Collier, DA ;
Li, T ;
McLeod, HL .
PHARMACOGENETICS, 1999, 9 (01) :37-42
[9]   Shattuck lecture - Medical and societal consequences of the human genome project [J].
Collins, FS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :28-37
[10]  
DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P251